Presumed entecavir-induced ocular toxicity.
作者信息
Muqit M K M, Stanga P E, Vilar F J, Patton N
出版信息
Eye (Lond). 2011 Dec;25(12):1665-8. doi: 10.1038/eye.2011.259. Epub 2011 Oct 21.
Abstract
摘要
相似文献
1
Presumed entecavir-induced ocular toxicity.推测为恩替卡韦引起的眼部毒性。
Eye (Lond). 2011 Dec;25(12):1665-8. doi: 10.1038/eye.2011.259. Epub 2011 Oct 21.
2
Reversible retinal toxicity in early oral Entecavir therapy for hepatitis-B infection.早期口服恩替卡韦治疗乙型肝炎感染时的可逆性视网膜毒性。
Eye (Lond). 2018 Nov;32(11):1792-1794. doi: 10.1038/s41433-018-0156-6. Epub 2018 Jun 22.
3
Maculopapular-type drug eruption caused by entecavir.恩替卡韦引起的斑丘疹型药疹。
Eur J Dermatol. 2011 Jul-Aug;21(4):635-6. doi: 10.1684/ejd.2011.1411.
4
[Clinical characterization of peripheral neuropathy associated with entecavir in patients with HBV-induced cirrhosis].
Zhonghua Gan Zang Bing Za Zhi. 2012 Sep;20(9):707-8.
5
Immediate allergy, drug-induced eruption, by entecavir.恩替卡韦所致速发型过敏、药物性皮疹。
J Eur Acad Dermatol Venereol. 2009 Apr;23(4):487-9. doi: 10.1111/j.1468-3083.2008.02932.x.
6
Drug eruption due to entecavir: A case report and mini-review.恩替卡韦所致药疹：一例报告及文献综述
Allergol Int. 2016 Jul;65(3):334-5. doi: 10.1016/j.alit.2015.12.008. Epub 2016 Jan 23.
7
Entecavir: a potent new antiviral drug for hepatitis B.恩替卡韦：一种用于治疗乙型肝炎的强效新型抗病毒药物。
Expert Opin Investig Drugs. 2003 Apr;12(4):683-8. doi: 10.1517/13543784.12.4.683.
8
Interferon-associated retinopathy in a young, insulin-dependent diabetic patient.一名年轻的胰岛素依赖型糖尿病患者的干扰素相关性视网膜病变。
Retina. 2000;20(4):413-5. doi: 10.1097/00006982-200004000-00023.
9
A comparison of telbivudine and entecavir in the treatment of hepatitis B e antigen-positive patients: a prospective cohort study in China.替比夫定与恩替卡韦治疗乙型肝炎 e 抗原阳性患者的比较：中国的一项前瞻性队列研究。
Clin Microbiol Infect. 2016 Mar;22(3):287.e1-9. doi: 10.1016/j.cmi.2015.10.024. Epub 2015 Nov 5.
10
Emergence of Oncogenic-Enhancing Hepatitis B Virus X Gene Mutants in Patients Receiving Suboptimal Entecavir Treatment.接受恩替卡韦治疗效果欠佳患者中致癌性增强的乙型肝炎病毒X基因变异体的出现
Hepatology. 2019 May;69(5):2292-2296. doi: 10.1002/hep.30423. Epub 2019 Feb 14.
本文引用的文献
1
Revised recommendations on screening for chloroquine and hydroxychloroquine retinopathy.关于氯喹和羟氯喹视网膜病变筛查的修订建议。
Ophthalmology. 2011 Feb;118(2):415-22. doi: 10.1016/j.ophtha.2010.11.017.
2
Long-term entecavir therapy results in the reversal of fibrosis/cirrhosis and continued histological improvement in patients with chronic hepatitis B.长期使用恩替卡韦治疗可使慢性乙型肝炎患者的纤维化/肝硬化逆转，并持续改善组织学。
Hepatology. 2010 Sep;52(3):886-93. doi: 10.1002/hep.23785.
3
High-speed ultra-high-resolution optical coherence tomography findings in hydroxychloroquine retinopathy.羟氯喹视网膜病变的高速超高分辨率光学相干断层扫描结果
Arch Ophthalmol. 2007 Jun;125(6):775-80. doi: 10.1001/archopht.125.6.775.
4
A comparison of entecavir and lamivudine for HBeAg-positive chronic hepatitis B.恩替卡韦与拉米夫定治疗HBeAg阳性慢性乙型肝炎的比较。
N Engl J Med. 2006 Mar 9;354(10):1001-10. doi: 10.1056/NEJMoa051285.
5
Oculotoxicities of systemically administered drugs.全身给药药物的眼毒性。
J Ocul Pharmacol. 1986 Fall;2(4):385-404. doi: 10.1089/jop.1986.2.385.
Zotero 插件